HIGHLIGHTS
- who: Pina Ziranu from the Medical Oncology Unit, University Hospital have published the paper: CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors, in the Journal: Scientific Reports Scientific Reports of February/01,/2023
- what: Approval for the study was obtained by Ethics Committee of the University Hospital of Cagliari (Protocol number 2020/10,912-code: EMIBIOCCOR) and written informed consent was obtained from all participants for their tissues to be utilized for this work. The aim of the present analysis was to evaluate the role . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.